These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 35175580)
1. Serum concentrations of free indoxyl and p-cresyl sulfate are associated with mineral metabolism variables and cardiovascular risk in hemodialysis patients. Arcidiacono T; Macrina L; Premaschi S; Bologna A; Magni G; Foligno N; Avino M; Belloni C; Palmieri N; Conte F; Bisegna S; Simonini M; Slaviero G; Locatelli M; Vezzoli G J Nephrol; 2022 Jun; 35(5):1457-1465. PubMed ID: 35175580 [TBL] [Abstract][Full Text] [Related]
2. Meta-Analysis of the Associations of p-Cresyl Sulfate (PCS) and Indoxyl Sulfate (IS) with Cardiovascular Events and All-Cause Mortality in Patients with Chronic Renal Failure. Lin CJ; Wu V; Wu PC; Wu CJ PLoS One; 2015; 10(7):e0132589. PubMed ID: 26173073 [TBL] [Abstract][Full Text] [Related]
3. Removal of Protein-Bound Uremic Toxins during Hemodialysis Using a Binding Competitor. Madero M; Cano KB; Campos I; Tao X; Maheshwari V; Brown J; Cornejo B; Handelman G; Thijssen S; Kotanko P Clin J Am Soc Nephrol; 2019 Mar; 14(3):394-402. PubMed ID: 30755453 [TBL] [Abstract][Full Text] [Related]
4. Gastrointestinal-related uremic toxins in peritoneal dialysis: a pilot study with a 5-year follow-up. Lin CJ; Pan CF; Chuang CK; Liu HL; Sun FJ; Wang TJ; Chen HH; Wu CJ Arch Med Res; 2013 Oct; 44(7):535-41. PubMed ID: 24055267 [TBL] [Abstract][Full Text] [Related]
6. p-Cresyl sulfate and indoxyl sulfate in hemodialysis patients. Meijers BK; De Loor H; Bammens B; Verbeke K; Vanrenterghem Y; Evenepoel P Clin J Am Soc Nephrol; 2009 Dec; 4(12):1932-8. PubMed ID: 19833905 [TBL] [Abstract][Full Text] [Related]
7. The relationship of indoxyl sulfate and p-cresyl sulfate with target cardiovascular proteins in hemodialysis patients. Wu PH; Lin YT; Chiu YW; Baldanzi G; Huang JC; Liang SS; Lee SC; Chen SC; Hsu YL; Kuo MC; Hwang SJ Sci Rep; 2021 Feb; 11(1):3786. PubMed ID: 33589722 [TBL] [Abstract][Full Text] [Related]
8. Free p-cresyl sulfate shows the highest association with cardiovascular outcome in chronic kidney disease. Glorieux G; Vanholder R; Van Biesen W; Pletinck A; Schepers E; Neirynck N; Speeckaert M; De Bacquer D; Verbeke F Nephrol Dial Transplant; 2021 May; 36(6):998-1005. PubMed ID: 33508125 [TBL] [Abstract][Full Text] [Related]
9. The Accumulation of Gut Microbiome-derived Indoxyl Sulfate and P-Cresyl Sulfate in Patients With End-stage Renal Disease. Lin X; Liang W; Li L; Xiong Q; He S; Zhao J; Guo X; Xiang S; Zhang P; Wang H; Ying C; Yao Y; Zuo X J Ren Nutr; 2022 Sep; 32(5):578-586. PubMed ID: 34736844 [TBL] [Abstract][Full Text] [Related]
10. Chen Z; Xu J; Xing X; Xue C; Luo X; Gao S; Mao Z Ren Fail; 2022 Dec; 44(1):1791-1800. PubMed ID: 36278836 [TBL] [Abstract][Full Text] [Related]
11. Indoxyl sulfate, not P-cresyl sulfate, is associated with advanced glycation end products in patients on long-term hemodialysis. Lin CJ; Lin J; Pan CF; Chuang CK; Liu HL; Sun FJ; Wang TJ; Chen HH; Wu CJ Kidney Blood Press Res; 2015; 40(2):121-9. PubMed ID: 25833743 [TBL] [Abstract][Full Text] [Related]
12. Serum free p-cresyl sulfate levels predict cardiovascular and all-cause mortality in elderly hemodialysis patients--a prospective cohort study. Wu IW; Hsu KH; Hsu HJ; Lee CC; Sun CY; Tsai CJ; Wu MS Nephrol Dial Transplant; 2012 Mar; 27(3):1169-75. PubMed ID: 21891772 [TBL] [Abstract][Full Text] [Related]
13. Associations among total p-cresylsulfate, indoxyl sulfate and hippuric acid levels with hemodialysis quality indicators in maintenance hemodialysis patients. Lu YC; Wu CC; Tsai IT; Hung WC; Lee TL; Hsuan CF; Yu TH; Wei CT; Chung FM; Lee YJ; Wang CP Clin Chim Acta; 2021 May; 516():83-91. PubMed ID: 33508250 [TBL] [Abstract][Full Text] [Related]
14. Serum concentrations of p-cresyl sulfate and indoxyl sulfate, but not inflammatory markers, increase in incident peritoneal dialysis patients in parallel with loss of residual renal function. Viaene L; Meijers BK; Bammens B; Vanrenterghem Y; Evenepoel P Perit Dial Int; 2014; 34(1):71-8. PubMed ID: 24179107 [TBL] [Abstract][Full Text] [Related]
16. The role of protein-bound uremic toxins on peripheral artery disease and vascular access failure in patients on hemodialysis. Lin CJ; Pan CF; Liu HL; Chuang CK; Jayakumar T; Wang TJ; Chen HH; Wu CJ Atherosclerosis; 2012 Nov; 225(1):173-9. PubMed ID: 22981405 [TBL] [Abstract][Full Text] [Related]
17. Protein-bound uremic toxins, inflammation and oxidative stress: a cross-sectional study in stage 3-4 chronic kidney disease. Rossi M; Campbell KL; Johnson DW; Stanton T; Vesey DA; Coombes JS; Weston KS; Hawley CM; McWhinney BC; Ungerer JP; Isbel N Arch Med Res; 2014 May; 45(4):309-17. PubMed ID: 24751327 [TBL] [Abstract][Full Text] [Related]
18. Protein-bound uremic toxin lowering strategies in chronic kidney disease: a systematic review and meta-analysis. Takkavatakarn K; Wuttiputinun T; Phannajit J; Praditpornsilpa K; Eiam-Ong S; Susantitaphong P J Nephrol; 2021 Dec; 34(6):1805-1817. PubMed ID: 33484425 [TBL] [Abstract][Full Text] [Related]
19. Efficacy of Divinylbenzenic Resin in Removing Indoxyl Sulfate and P-Cresol Sulfate in Hemodialysis Patients: Results From an In Vitro Study and An In Vivo Pilot Trial (xuanro4-Nature 3.2). Rocchetti MT; Cosola C; di Bari I; Magnani S; Galleggiante V; Scandiffio L; Dalfino G; Netti GS; Atti M; Corciulo R; Gesualdo L Toxins (Basel); 2020 Mar; 12(3):. PubMed ID: 32164382 [TBL] [Abstract][Full Text] [Related]
20. Renal clearance and intestinal generation of p-cresyl sulfate and indoxyl sulfate in CKD. Poesen R; Viaene L; Verbeke K; Claes K; Bammens B; Sprangers B; Naesens M; Vanrenterghem Y; Kuypers D; Evenepoel P; Meijers B Clin J Am Soc Nephrol; 2013 Sep; 8(9):1508-14. PubMed ID: 23813557 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]